Trial Profile
Phase II Study of Z-206 in Patients with Active Crohn's Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Mar 2020
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary)
- Indications Crohn's disease
- Focus Adverse reactions; Therapeutic Use
- Sponsors Zeria
- 25 May 2016 New trial record